132 related articles for article (PubMed ID: 34662828)
21. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A2A Adenosine Receptor: Prediction from Molecular Modeling.
Bharate SB; Singh B; Kachler S; Oliveira A; Kumar V; Bharate SS; Vishwakarma RA; Klotz KN; Gutiérrez de Terán H
J Med Chem; 2016 Jun; 59(12):5922-8. PubMed ID: 27227326
[TBL] [Abstract][Full Text] [Related]
23. Diastereoisomers of 2-benzyl-2, 3-dihydro-2-(1H-inden-2-yl)-1H-inden-1-ol: potential anti-inflammatory agents.
Sheridan H; Walsh JJ; Cogan C; Jordan M; McCabe T; Passante E; Frankish NH
Bioorg Med Chem Lett; 2009 Oct; 19(20):5927-30. PubMed ID: 19740655
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and pharmacological evaluation of 2-(thiazol-2-amino)-4-arylaminopyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Liu Z; Yue X; Song Z; Peng X; Guo J; Ji Y; Cheng Z; Ding J; Ai J; Geng M; Zhang A
Eur J Med Chem; 2014 Oct; 86():438-48. PubMed ID: 25200979
[TBL] [Abstract][Full Text] [Related]
25. One-pot synthesis of thiazolo[3,2-a]pyrimidine derivatives, their cytotoxic evaluation and molecular docking studies.
Sekhar T; Thriveni P; Venkateswarlu A; Daveedu T; Peddanna K; Sainath SB
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Apr; 231():118056. PubMed ID: 32006911
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin receptor modulators and their therapeutic potential.
Costantino L; Barlocco D
Future Med Chem; 2009 Apr; 1(1):157-77. PubMed ID: 21426074
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder.
Farokhnia M; Faulkner ML; Piacentino D; Lee MR; Leggio L
Physiol Behav; 2019 May; 204():49-57. PubMed ID: 30738971
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands.
Di Stefano A; Sozio P; Luisi G; Cacciatore I; Mosciatti B; Costa B; Lucacchini A; Martini C; Pinnen F
Farmaco; 2002 Apr; 57(4):303-13. PubMed ID: 11989809
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation.
Diab S; Teo T; Kumarasiri M; Li P; Yu M; Lam F; Basnet SK; Sykes MJ; Albrecht H; Milne R; Wang S
ChemMedChem; 2014 May; 9(5):962-72. PubMed ID: 24677692
[TBL] [Abstract][Full Text] [Related]
31. Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease.
Kadayat TM; Banskota S; Gurung P; Bist G; Thapa Magar TB; Shrestha A; Kim JA; Lee ES
Eur J Med Chem; 2017 Sep; 137():575-597. PubMed ID: 28646757
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and preliminary biological evaluation of [
Gao M; Wang M; Meyer JA; Peters JS; Zarrinmayeh H; Territo PR; Hutchins GD; Zheng QH
Bioorg Med Chem Lett; 2017 Jun; 27(12):2727-2730. PubMed ID: 28462835
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of an UPLC-MS/MS assay for quantitative analysis of the ghrelin receptor inverse agonist PF-5190457 in human or rat plasma and rat brain.
Ghareeb M; Leggio L; El-Kattan A; Akhlaghi F
Anal Bioanal Chem; 2015 Jul; 407(19):5603-13. PubMed ID: 25943263
[TBL] [Abstract][Full Text] [Related]
34. 2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activity.
Wang S; Meades C; Wood G; Osnowski A; Anderson S; Yuill R; Thomas M; Mezna M; Jackson W; Midgley C; Griffiths G; Fleming I; Green S; McNae I; Wu SY; McInnes C; Zheleva D; Walkinshaw MD; Fischer PM
J Med Chem; 2004 Mar; 47(7):1662-75. PubMed ID: 15027857
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of agonism and inverse agonism in ghrelin receptor.
Qin J; Cai Y; Xu Z; Ming Q; Ji SY; Wu C; Zhang H; Mao C; Shen DD; Hirata K; Ma Y; Yan W; Zhang Y; Shao Z
Nat Commun; 2022 Jan; 13(1):300. PubMed ID: 35027551
[TBL] [Abstract][Full Text] [Related]
36. Indene Compounds Synthetically Derived from Vitamin D Have Selective Antibacterial Action on Helicobacter pylori.
Wanibuchi K; Hosoda K; Ihara M; Tajiri K; Sakai Y; Masui H; Takahashi T; Hirai Y; Shimomura H
Lipids; 2018 Apr; 53(4):393-401. PubMed ID: 29766504
[TBL] [Abstract][Full Text] [Related]
37. Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold.
Schwertz G; Witschel MC; Rottmann M; Leartsakulpanich U; Chitnumsub P; Jaruwat A; Amornwatcharapong W; Ittarat W; Schäfer A; Aponte RA; Trapp N; Chaiyen P; Diederich F
ChemMedChem; 2018 May; 13(9):931-943. PubMed ID: 29655285
[TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy.
Wong H; Belvin M; Herter S; Hoeflich KP; Murray LJ; Wong L; Choo EF
J Pharmacol Exp Ther; 2009 Apr; 329(1):360-7. PubMed ID: 19147858
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship studies and pharmacological characterization of N
Varano F; Catarzi D; Vincenzi F; Falsini M; Pasquini S; Borea PA; Colotta V; Varani K
Eur J Med Chem; 2018 Jul; 155():552-561. PubMed ID: 29909340
[TBL] [Abstract][Full Text] [Related]
40. WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
Brennan JA; Graf R; Grauer SM; Navarra RL; Pulicicchio CM; Hughes ZA; Lin Q; Wantuch C; Rosenzweig-Lipson S; Pruthi F; Lai M; Smith D; Goutier W; van de Neut M; Robichaud AJ; Rotella D; Feenstra RW; Kruse C; Broqua P; Beyer CE; McCreary AC; Pausch MH; Marquis KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):190-201. PubMed ID: 19828876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
